A patient with premature coronary heart disease and aortic stenosis is described in whom the diagnosis of phytosterolaemia was made by gas chromatographic analysis of plant sterols in plasma and aortic tissue. The clinical presentation mimicked familial hypercholesterolaemia. The plasma concentration of low density lipoprotein (LDL) cholesterol was elevated due to both reduced catabolism and increased synthesis of LDL-apolipoprotein B. Phytosterolaemia was responsive to cholestyramine but not to a~ow plant sterol diet alone.
CLINICAL REPORT
A 33-year-old man presented with progressive dyspnoea on exertion and painful swelling of both heels; he did not admit to chest or calf pain, nor to haemoptysis. He was a non-smoker and had not previously suffered from rheumatic or scarlet fever. There was no history of systemic hypertension. He had large Achilles tendon xanthomata, small xanthomata of the extensor tendons of the hands, xanthelasma palpebrarum and an arcus corneae (Fig. 1) . The body mass index was 27· 1 kg/rn-, the systemic blood pressure 120/90 mmHg and there was a moderately loud ejection systolic murmur; he was not in cardiac failure and all peripheral pulses were present. Deep venous thrombosis, pulmonary embolism and pneumothorax were excluded clinically. He was not anaemic and there was no organomegaly. Neurological examination was normal. There was no proteinuria on dipstick urinalysis. The parents were consanguinous, the family history being negative for premature cardiovascular disease. An electrocardiogram showed sinus rhythm at a rate of SO/min, left Correspondence: Dr G F Walls. ventricular hypertrophy and ST depression in the anterior chest leads. Pulmonary venous hypertension was noted on a chest X-ray. He was referred for cardiac angiography. This revealed tight supravalvular aortic stenosis and extensive atheromatous disease of the right and left coronary arteries.
Venous blood was collected in the fasting state (on at least three occasions) into tubes containing Na2EDTA (final concentration 1 mg/mL) for lipid, lipoprotein, apolipoprotein and sterol analyses. Samples were also obtained to exclude secondary causes of hyperlipidaemia. First degree relatives (both parents, six siblings and four offspring) were initially screened for hyperlipidaemia alone.
Because of rapidly progressive symptoms the patient proceeded to aortic root replacement and coronary artery bypass surgery, from which he made an excellent recovery. A biopsy of aortic tissue was obtained at operation for sterol analysis. Three months post-operatively a radiokinetic study of the metabolism of LDL-apo B was carried out using the study protocol of Sigurdsson et al;I blood was also collected for the in vitro assessment of LDL receptor activity. The patient was on an ad libitum diet throughout the above investigations.
ANALYTICAL METHODS
The plasma concentration of cholesterol was measured by the CHOD-PAP enzymatic colorimetric method (Boehringer, Lewes, UK), with an interassay coefficient of variation (CV) of < 3· 5070. Plasma triglyceride was also measured by an enzymatic method (Wako Chemicals, Neuss, Germany); interassay CV <3%. High density lipoprotein (HDL) cholesterol was assayed after the precipitation of apo B with MnCl 2 and heparin. LDL cholesterol was measured after isolation of LDL at plasma density d= 1·063 g/mL using preparative ultracentrifugation. Apo B was The degradation of IHI-Iabelled human LDL by freshly isolated blood mononuclear cells was measured as described by Bilheimer et 01. 3 Plant sterols in plasma were quantitated by gas chromatography (GC) after hydrolysis and extraction." Coprostanol (Steraloids Ltd, Croydon, UK) was used as the internal standard and taken through the complete procedure. The ratios of chromatographic peak heights of plant sterols to coprostanol in the test sample were compared with those from a set of sterol standards (Sigma Chemicals, Dorset, UK plant sterols and cholestanol were measured in an aortic biopsy using the same method as described for plasma.
RESULTS
The concentration of lipids, lipoproteins, apo B, plant sterols and cholestanol in plasma, and the kinetic parameters of LDL apo B and the LDL receptor activity are given in Table I ; reference values were obtained from the Iiterature 2 • S -8 and for conventional measurements should be distinguished from so-called 'desirable' values.v'? Cholesterol, LDL cholesterol and apo B concentrations were all elevated. This was consistent with the low FCR and high synthetic rate of LDL-apo B and low LDL receptor activity. Beta-sitosterol and campesterol were both markedly elevated in plasma; the concentration of cholestanol was also increased, but to a lesser extent than the plant sterols.
Stigmasterol was not identified. The plant sterols in the patient's plasma are demonstrated in the GC tracings shown in Fig. 2a; Figs 2b and care control and standards, respectively. sterols and cholestanol was markedly increased compared with control material.U-t-The above findings were diagnostic of phytosterolaemia associated with reduced catabolism and increased synthesis of LDL apo B. Heterozygous familial hypercholesterolaemia, the most likely diagnosis at initial presentation, was excluded since all relatives studied were normolipidaemic (plasma cholesterol < 6· 0, LDL cholesterol <4'5, triglyceride <2'5 mmol/L) and none had xanthomatosis. The patient did not show biochemical evidence of diabetes mellitus, hypothyroidism, renal insufficiency or abnormal liver function. The plasma phytosterol and cholesterol levels did not alter significantly after a period of 3 months on isocaloric, low plant sterol diet (60 mg/day) with regular review by a dietitian. However, the addition of cholestyramine (16 g/day), a bile acid-binding resin, resulted in a significant fall in phytosterols (-23010), cholesterol (-36010) and LDL cholesterol (-43010) .
DISCUSSION
Phytosterolaemia, originally termed 'sitosterolaemia and xanthomatosis', 13 is a rare autosomal recessive disorder in which plant sterols accumulate in the plasma and tissues. 8 • 13 • 14 Only twentythree cases have hitherto been reported. 14, 15 The external clinical signs in this patient are typical of the disorder, but may also be seen in familial hypercholesterolaemia and cerebotendinous xanthomatosis. 16 Premature coronary heart disease is a well-recognized complication, particularly in men.:" A novel finding was the extensive supravalvular aortic stenosis due to accumulation of cholesterol and plant sterols in aortic tissue. Unlike cerebotendinous xanthomatosis neurological lesions are not seen."
Elevated plasma and tissue levels of {1-sitosterol and campesterol, the most common plant sterols, are diagnostic of phytosterolaernia. \3.\4 Hypercholesterolaemia and hypercholestanolaernia are less consistent findings.lv'" The plasma level of cholestanol may be similar to that seen in cerebotendinous xanthomatosis," but the latter is distinguished by accumulation of cholestanol in the brain, neurological abnormalities and absence of phytosterolaemia. The bases for premature atherosclerosis in phytosterolaemia have not yet been established, but are likely to relate to the increased uptake of plant sterols by endothelial cells and macrophages.'? In this patient the elevated plasma concentration of LDL apo B must have also contributed to the vascular injury.l" We provide the first evidence that the elevation in plasma apo B previously described in phytosterolaemics'? is due to a combination of increased synthesis and reduced clearance of LDL apo B. Both mechanisms are compatible with a reduction in LDL receptor activity," although we cannot exclude that increased synthesis of LDL apo B was also due to increased hepatic secretion of VLDL apo B.20 Since there was no evidence of hypercholesterolaemia or xanthomatosis in the patient's immediate relatives, it is more probable that reduction in LDL receptor activity was due to the metabolic defect in phytosterolaemia than to a primary hyperlipidaemia, such as polygenic or familial hypercholesterolaemia. Absence of familial combined hyperlipidaemia also militates against hepatic oversecretion of apo B. 6 The metabolic bases for phytosterolaemia have not been fully elucidated. The available evidence suggests increased intestinal absorption coupled with reduced hepatic excretion of plant sterols. 14 Normally less than 5010 of plant sterols in the diet are absorbed, but in phytosterolaemia this can increase to 30010. 13 Marked reduction in the biliary excretion of sterols has also been demonstrated," consistent with a low turnover rate of intravenously injected [3H] -sitosterol. 22 An additional defect might be an impaired formation of bile acids. 12 In humans 70010 of phytosterols circulate in plasma in LDL particles. The reduced FCR of LDL apo B noted in our patient concurs with a defect in the hepatic handling and excretion of sterols. 12,20,22 LDL receptor activity is reciprocally related to the intrahepatic pool of cholesterol. 23 The poor response of phytosterolaemia to dietary restriction of plant sterols compared with the significant fall following addition of cholestyramine also suggests that in this patient reduced biliary excretion of sterols was probably a more important lesion than an increase in their absorption. Cholestyramine, a resin which binds bile acids in the gut, enhances the intrahepatic conversion of sterols to bile acids-" and lowers cholesterol and phytosterols in plasma by increasing LDL receptor activity. 14,25 The mechanism for the hypercholestanolaemia remains unexplained, but might also involve the removal defect proposed above. This defect will need to be confirmed using sterol balance and radiokinetic studies.
Phytosterolaemia must be considered in all patients with xanthomatosis and hypercholesterolaemia, especially if there is a negative family history of premature cardiovascular disease and relatives are normolipidaemic. Since its inheritance is autosomal recessive, the diagnosis should also be suspected with parental consanguinity. 13 .14 The biochemical diagnosis is readily made by GC analysis of plant sterols in plasma, with definitive evidence derived from direct assay of affected tissue.
Establishing the diagnosis is important because the dietary treatment is radically different from that where an elevation in LDL cholesterol is the sole abnormality. 14 Bile acid-binding resins should be used when there is a poor response to a diet low in, or free from, plant sterols. Since lowering plasma cholesterol and phytosterols has been shown to result in regression of xanthomata," phytosterolaemia must be considered a treatable cause of premature atherosclerosis.
